Evidence map›Paper›PMID 38191593›Full record

ArticleOncogenesis2024

A cyclin D1 intrinsically disordered domain accesses modified histone motifs to govern gene transcription.

Xuanmao Jiao, Gabriele Di Sante, Mathew C Casimiro, Agnes Tantos, Anthony W Ashton, Zhiping Li, Yen Quach, Dharmendra Bhargava, Agnese Di Rocco, Claudia Pupo and 13 more

Open access · goldAbstract read
In one paragraph

Article in Oncogenesis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 10 institutions in 5 countries.

Xuanmao Jiao *Baruch S. Blumberg Institute, Doylestown, PA, 18902, USA.
Gabriele Di Sante *Baruch S. Blumberg Institute, Doylestown, PA, 18902, USA.
Mathew C CasimiroBaruch S. Blumberg Institute, Doylestown, PA, 18902, USA.
Agnes TantosInstitute of Enzymology, Hun-Ren Research Centre for Natural Sciences, Budapest, Hungary.
Anthony W AshtonBaruch S. Blumberg Institute, Doylestown, PA, 18902, USA.ORCID http://orcid.org/0000-0001-6063-1566
Zhiping LiBaruch S. Blumberg Institute, Doylestown, PA, 18902, USA.
Yen QuachXavier University School of Medicine at Aruba, Oranjestad, Aruba.
Dharmendra BhargavaBaruch S. Blumberg Institute, Doylestown, PA, 18902, USA.ORCID http://orcid.org/0000-0002-9938-5515
Agnese Di RoccoBaruch S. Blumberg Institute, Doylestown, PA, 18902, USA.
Claudia PupoDepartment of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
Marco CrosariolDepartment of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
Tamas LazarVIB-VUB Center for Structural Biology, Vrije Universiteit Brussel, Brussels, 1050, Belgium.ORCID http://orcid.org/0000-0001-7496-6711
Peter TompaInstitute of Enzymology, Hun-Ren Research Centre for Natural Sciences, Budapest, Hungary.
Chenguang WangDepartment of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
Zuoren YuResearch Center for Translational Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.ORCID http://orcid.org/0000-0003-4196-9662
Zhao ZhangBaruch S. Blumberg Institute, Doylestown, PA, 18902, USA.
Kawthar AldaaysiXavier University School of Medicine at Aruba, Oranjestad, Aruba.
Ratna VadlamudiDepartment of Obstetrics and Gynecology, University of Texas Health Sciences Center, San Antonio, TX, 78229, USA.ORCID http://orcid.org/0000-0003-2849-4076
Monica MannDepartment of Obstetrics and Gynecology, University of Texas Health Sciences Center, San Antonio, TX, 78229, USA.
Emmanuel SkordalakesThe Wistar Institute, Philadelphia, PA, 19107, USA.
Andrew KossenkovThe Wistar Institute, Philadelphia, PA, 19107, USA.
Yanming DuBaruch S. Blumberg Institute, Doylestown, PA, 18902, USA.
Richard G PestellBaruch S. Blumberg Institute, Doylestown, PA, 18902, USA. richard.pestell@bblumberg.org.ORCID http://orcid.org/0000-0003-3244-8777
Baruch S. Blumberg Institute · USUniversity of Aruba · AWThe Wistar Institute · USThomas Jefferson University · USThe University of Texas Health Science Center at San Antonio · USVrije Universiteit Brussel · BEAbraham Baldwin Agricultural College · USInstitute of Molecular Life Sciences · HULankenau Institute for Medical Research · USShanghai East Hospital · CN

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Maureen E. Murphy · 1985 to 2026
$75.9M
DACH1/Eya Cell fate determination factor and mammary tumorigenesisR01CA132115 · NCI · THOMAS JEFFERSON UNIVERSITY · PI PESTELL, RICHARD G · 2009 to 2018
$3.1M
Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center LevelR50CA211199 · NCI · WISTAR INSTITUTE · PI Andrew V Kossenkov · 2016 to 2026
$1.6M
CCR5 inhibitors to enhance therapeutic response of breast cancer to DNA damaging agentsR21CA235139 · NCI · BARUCH S. BLUMBERG INSTITUTE · PI PESTELL, RICHARD G · 2020 to 2020
$383k
NCI NIH HHS P30 CA010815NCI NIH HHS R01 CA132115NCI NIH HHS R21 CA235139NCI NIH HHS R50 CA211199
6 · The paper itself

Abstract

The essential G

Identifiers

PMID38191593
PMCPMC10774418
OpenAlexW4390673430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.